Can a 60-year-old adult develop cystic fibrosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can a Person Get Cystic Fibrosis in Their 60s?

No, a person cannot "get" or "develop" cystic fibrosis in their 60s—cystic fibrosis is a genetic disease present from birth—but they can absolutely be diagnosed with CF for the first time at age 60 or older if the disease went unrecognized earlier in life.

Understanding Late CF Diagnosis

Cystic fibrosis is an autosomal recessive genetic condition that you are born with, not something acquired later in life 1. However, diagnosis in the 60s and beyond does occur, particularly in individuals with milder, atypical presentations that evaded earlier detection.

Current Evidence on Older Adults with CF

Recent registry data shows that 22% of people with CF in the United States are now 60 years or older (1,146 individuals in 2022), with this group having unique characteristics including later diagnosis and a greater proportion being female (58%) 2. This demonstrates that late diagnosis, even into the seventh decade, is a recognized clinical reality.

Clinical Characteristics of Late-Diagnosed CF

Adults diagnosed at age 60 or older typically present with distinct features 3, 4:

Respiratory manifestations:

  • Predominantly upper lobe bronchiectasis
  • Chronic respiratory symptoms previously misdiagnosed as asthma, chronic bronchitis, or emphysema
  • Lower incidence of Pseudomonas aeruginosa colonization
  • More common Staphylococcus aureus infections (50% in one series)
  • Normal or only mildly obstructive lung function

Pancreatic and other features:

  • Usually pancreatic sufficient (unlike childhood-diagnosed CF where 85% have pancreatic insufficiency) 1
  • May present with pancreatitis rather than pancreatic insufficiency
  • Congenital bilateral absence of vas deferens in males
  • Chronic sinusitis and nasal polyps

Genetic profile:

  • More likely to have mutations other than ΔF508 (the most common mutation accounting for 30-88% of CF chromosomes) 1, 3
  • Often heterozygotes for F508del 4

Diagnostic Approach for Suspected Late CF

When evaluating a 60-year-old with unexplained bronchiectasis, chronic respiratory infections, or pancreatitis, consider CF and proceed with:

  1. Sweat chloride testing (diagnostic threshold >60 mEq/L) 1, 4
  2. CFTR genetic testing if sweat test is positive or borderline
  3. High-resolution chest CT to evaluate for characteristic upper lobe bronchiectasis
  4. Sputum cultures for typical CF pathogens

Critical pitfall: The most common error is failing to consider CF in older adults with chronic respiratory symptoms because of the misconception that CF is exclusively a childhood disease 5, 6.

Clinical Implications

Prognosis for late-diagnosed patients is generally more favorable than for those diagnosed in infancy, with milder disease progression 6. However, bronchiectasis can still be severe despite later diagnosis, and appropriate CF-specific treatment and monitoring are essential once the diagnosis is established.

Genetic counseling is crucial even for older adults, as family members may be carriers or have undiagnosed mild disease 4.

The key message: While CF cannot be "acquired" in one's 60s, it can certainly be diagnosed for the first time at this age, and clinicians must maintain appropriate clinical suspicion in adults with compatible respiratory or pancreatic manifestations 3, 4, 7.

References

Guideline

standards and guidelines for cftr mutation testing.

Genetics in Medicine, 2002

Research

Aging with CF: Characteristics of people with CF aged 40 and older in the United States.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2025

Research

Manifestations of cystic fibrosis diagnosed in adulthood.

Current opinion in pulmonary medicine, 2005

Research

Diagnosing Cystic Fibrosis in Adults.

Seminars in respiratory and critical care medicine, 2023

Related Questions

In a 17-year-old male with cystic fibrosis, which of the following statements is incorrect?
In an 18‑year‑old male with cystic fibrosis, mild obstructive disease on prior spirometry and current cough with yellow‑green sputum, which is the most appropriate next test to assess disease severity: arterial blood gas analysis, repeat spirometry, chest radiograph, or chest computed tomography?
In a hemodynamically stable, afebrile cystic fibrosis patient with a productive cough, purulent sputum, and a normal white blood cell count, what is the most appropriate next step in management?
What symptoms indicate a pulmonary flare in a patient with cystic fibrosis?
Can you explain the detailed step-by-step pathophysiology of cystic fibrosis?
Is Ehlers‑Danlos syndrome, especially the vascular type (type III), associated with intracranial (brain) aneurysms?
How should Systane Max (preservative‑free lubricating eye drops) be used for dry eye, including dosing, administration, and safety considerations?
What are the latest guidelines for treating eczema flares in a 2‑year‑old child with topical creams?
What is the recommended plan to taper nortriptyline and manage insomnia in a 63-year-old woman with sleep fragmentation, low daytime sleepiness, and a history of osteoporosis and other comorbidities?
What is the recommended dose of ondansetron for adult patients?
For an adult patient with a coronary calcium score of 3.3 Agatston units, what is the clinical significance and recommended management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.